CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells

Understanding the mechanism of chemoresistance and disease progression in patients with prostate cancer is important for developing novel treatment strategies. In particular, developing resistance to cabazitaxel is a major challenge in patients with docetaxel‐resistant and castration‐resistant prost...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Natsagdorj, Ariunbold, Izumi, Kouji, Hiratsuka, Kaoru, Machioka, Kazuaki, Iwamoto, Hiroaki, Naito, Renato, Makino, Tomoyuki, Kadomoto, Suguru, Shigehara, Kazuyoshi, Kadono, Yoshifumi, Lin, Wen‐Jye, Maolake, Aerken, Mizokami, Atsushi
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6317938/
https://ncbi.nlm.nih.gov/pubmed/30426599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13876
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares